LFG
TERN

Larson Financial Group’s Terns Pharmaceuticals TERN Stock Holding History

Larson Financial Group’s Portfolio TERN Stock Details TERN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.53K Buy
29
+18
+164% +$739 ﹤0.01% 3039
2025
Q4 		$444 Buy
+11
New +$254 ﹤0.01% 3146
2025
Q1 		– Sell
-917
Closed -$5.08K – 3199
2024
Q4 		$5.08K Buy
+917
New +$6.21K ﹤0.01% 1661

Other funds holding TERN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

Larson Financial Group's TERN Position: Q1 2026 in Review

Larson Financial Group increased its Terns Pharmaceuticals (TERN) stake by 164% in Q1 2026, buying an estimated $739 and bringing the position to 29 shares worth $1.53K. The position accounts for ﹤0.01% of the portfolio, ranked #3039.

Larson Financial Group first reported a position in TERN in Q4 2024 and has held it in 3 quarters since. The position peaked at $5.08K in Q4 2024. 317 funds tracked by Wall St. Rank hold TERN as of Q1 2026.

  • Larson Financial Group held 29 shares of Terns Pharmaceuticals worth $1.53K as of Q1 2026.
  • Larson Financial Group bought 18 Terns Pharmaceuticals shares in Q1 2026, an estimated $739.
  • Terns Pharmaceuticals made up ﹤0.01% of Larson Financial Group's portfolio in Q1 2026, its #3039 holding.
  • Larson Financial Group first reported a position in Terns Pharmaceuticals in Q4 2024 and has held it in 3 quarters since.
  • Larson Financial Group's Terns Pharmaceuticals position peaked at $5.08K in Q4 2024.
  • 317 funds tracked by Wall St. Rank held Terns Pharmaceuticals as of Q1 2026.

Based on Larson Financial Group's 13F filing for Q1 2026, filed 15 May 2026.